Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study.

Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study.

Item
http://www.wikidata.org/entity/Q33937441
Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapyIn Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers.Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials.Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma.The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience.Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma.Phamacology of fluticasone furoate and vilanterol trifenatate combination therapy for asthma.Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma.Ease of use of the ELLIPTA dry powder inhaler: data from three randomised controlled trials in patients with asthma.
P2860

Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study.

Item
http://www.wikidata.org/entity/Q33937441
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Efficacy and safety of flutica ...... s: a 24-week randomised study.
@ast
Efficacy and safety of flutica ...... s: a 24-week randomised study.
@en
type
label
Efficacy and safety of flutica ...... s: a 24-week randomised study.
@ast
Efficacy and safety of flutica ...... s: a 24-week randomised study.
@en
prefLabel
Efficacy and safety of flutica ...... s: a 24-week randomised study.
@ast
Efficacy and safety of flutica ...... s: a 24-week randomised study.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Efficacy and safety of flutica ...... s: a 24-week randomised study.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932